National Hispanic Science Network Early Stage Career Mentoring for NIDA Research

这份修订后的R25摘要澄清了拟议的国家拉美裔科学网络 (NHSN)NIDA Research职业早期指导计划(ECSM)解决了当前 西班牙裔少数族裔在NIHINIDA主要调查人员中代表性不足，并将 为西班牙裔早期职业生涯阶段的牙医提供培训和人员，包括未来 我是艾滋病研究人员。NSHN网络由40名由NIDA资助的导师组成，由3名资深导师领导 具有HIV-1艾滋病研究经验的科学家(安东尼、卡斯特罗、潘丁)。建议HN I爱滋病 培训和指导部分将由18名经验丰富的导师提供，最近 NIDA RO1或K型艾滋病研究项目奖。此操作的背景条件 该计划包括宝贵的NIH临床研究进展，但在NIH科学方面有些效率低下 教育过程，未开发的科学领导人才，以及许多符合NIH条件的机构 以及NIH有有限研究存在或没有研究存在的国会选区。寻求解决 在这样的条件下，ECSM模式现在弥合了一个具体的博士后科学教育鸿沟 分离(1)一方的初步研究培训，和(2)成功获得第一个NIH K-OR ROL项目奖在另一边。现在有多年生物医学科学教育的机会 面向博士后和博士后实习生，但达到K-或RO1的实习生相对较少 奖励成功。符合条件的ECSM研究员将是训练有素的高级教职员工科学家 在职业生涯的早期阶段，优先考虑符合NIH R15资格的机构内的人员 学术研究促进奖。NHSN‘导师文化’模式匹配 导师-指导每个研究员，并提供每周的网络研讨会和2次年度会议。一个 成功的K-或R01奖项是15个符合条件的NIDA和 将接受培训和指导的以西班牙裔为导向的研究员。如果NIDA的TLLIS模型 以拉美裔为导向的人成功了，它可能适合作为更广泛的NIH范围的K-Lite 导师奖励机制，以激发其他未被开发的PI级科学领导人才 在我国众多的生物医学研究实习生中。将鼓励所有15名ECSM研究员 使艾滋病毒I艾滋病成为未来研究的一个方面；有针对性的招募将确保一些 研究员将有一个主要的NIDA研究职业生涯承诺艾滋病毒I艾滋病研究。

This revised R25 summary clarifies that the proposed National Hispanic Science Network (NHSN) Early Career Stage Mentoring Program for NIDA Research (ECSM) addresses a current Hispanic minority under-representation among NIHINIDA principal investigators, and will provide training and men to ring for Hispanic early career stage sdentists, including future HN I AIDS researchers. The NSHN network of 40 NIDA-funded mentors is led by 3 senior scientists with HIV 1 AIDS research experience (Anthony, Castro, Pantin). Proposed HN I AIDS traininglmentoring components will be offered by the 18 experienced mentors with recent NIDA Ro1 or K-type awards for HIVIAIDS research projects. Background conditions for this program include treasured NIH clinicai research advances, but some inefficiency in NIH science education processes, untapped science leadership talent, and many NIH-eligible institutions and Congressional districts where NIH has limited or no research presence. Seeking to address such conditions, the ECSM model bridges a specific postdoctoral science education chasm now separating (1) initial research training on one side, and (2) successful receipt of a 1st NIH K- or ROl project award on the other side. Multi-year biomedical science education opportunities now exist for woos of pre- and post-doctoral trainees, but relatively few trainees achieve K- or Ro1 award success. Eligible ECSM fellows will be well-trained, advanced level faculty I staff scientists at early career stage, with priority given to those within institutions that qualify for NIH R15 Academic Research Enhancement Awards. An NHSN 'culture of mentorship' model matches mentor-guides with each fellow and provides weekly webinars and 2 annual meetings. A successful K- or R01 award is the planned outcome milestone for each of the 15 eligible NIDAand Hispanic-oriented fellows who will be trained and mentored. If tllis model for NIDA's Hispanic-oriented fellows succeeds, it may be adaptable as a more general NIH-wide 'K-lite' mentorship award mechanism to evoke otherwise untapped PI-level science leadership talents of our nation's many biomedical research trainees. All 15 ECSM fellows will be encouraged to make HIV I AIDS a facet of future research; targeted recruitment will ensure that some of the fellows will have a primary NIDA research career commitment to HIV I AIDS research.